NAB – The Morning Call · Tech hit by vaccine and antitrust moves. RBNZ today, less dovish perhaps?
0

Tech hit by vaccine and antitrust moves. RBNZ today, less dovish perhaps?

Wednesday 11th November 2020

Those vaccine hopes continue today, even though there were warnings from Fed officials that the economy still faced ongoing impacts from COVID-19, with structural differences highlighting the need for the fiscal stimulus that now seems unlikely to happen this year. NAB’s Rodrigo Catril says there’s also some caution over the vaccine news, and a response to antitrust action against Amazon ramping up in Europe. On today’s podcast there’s also discussion on yesterday’s NAB Business Survey, which showed business confidence picking up, and today’s RBNZ meeting – will they be less dovish that many had anticipated?

Leave a Reply

Your email address will not be published. Required fields are marked *

Scroll to top